Contribution of Pathological Alpha-synuclein as a Diagnostic Biomarker for Dementia With Lewy Bodies

Clinical trial NCT07166744 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07166744
Sponsor: University Hospital, Strasbourg, France
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Dementia With Lewy Bodies (DLB)Alzheimer's Disease (AD)

Start date: 2026-01-01
Primary completion: 2032-01-01
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.